Patient demographics | |||
---|---|---|---|
Characteristic | All N = 100 n(%) | Lung N = 78 n(%) | Head and neck N = 22 n(%) |
Age (years) | |||
 Median (range) | 67 (30–80) | 68.5 (40–80) | 63.5 (30–74) |
Gender | |||
 Male | 50 (50.0) | 36 (46.2) | 14 (63.6) |
 Female | 50 (50.0) | 42 (53.8) | 8 (36.4) |
Stage | |||
 I | 3 (3.0) | 2 (2.6) | 1 (4.5) |
 II | 6 (6.0) | 2 (2.5) | 4 (18.2) |
 III | 38 (38.0) | 32 (41.1) | 6 (27.3) |
 IV | 41 (41.0) | 36 (46.2) | 5 (22.7) |
 Limited* | 2 (2.0) | 2 (2.6) | - |
 Extensive* | 2 (2.0) | 2 (2.5) | - |
 Unknown | 8 (8.0) | 2 (2.5) | 6 (27.3) |
PS | Â | Â | Â |
 0 | 41 (41.0) | 26 (33.3) | 15 (68.2) |
 1 | 45 (45.0) | 40 (51.3) | 5 (22.7) |
 2 | 14 (14.0) | 12 (15.4) | 2 (9.1) |
ACE comorbidity Score | |||
 0 (None) | 37 (37.0) | 26 (33.3) | 11 (50.0) |
 1 (Mild) | 39 (39.0) | 31 (39.7) | 8 (36.4) |
 2 (Moderate) | 17 (17.0) | 16 (20.5) | 1 (4.5) |
 3 (Severe) | 7 (7.0) | 5 (6.5) | 2 (9.1) |